Results of the non-interventional TARGET study: Efficacy and safety of nilotinib in CML patients (pts) failing prior therapy in routine healthcare

Authors
Category Primary study
ConferenceOncology Research and Treatment
Year 2016
This article has no abstract
Epistemonikos ID: 80dcc6fa16c1d5508bcd8baad89daf3ac64ff28f
First added on: Apr 29, 2026